Teclison Ltd.
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| TATE and Pembrolizumab (MK3475) in mCRC and NSCLC (NCT04701476) | Teclison Ltd. | 2021-05-20 |
| TATE Versus TACE in Intermediate Stage HCC (NCT03145558) | Teclison Ltd. | 2017-12-05 |
Track Teclison Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.